FIA
ACHV icon

FNY Investment Advisers’s Achieve Life Sciences ACHV Stock Holding History

FNY Investment Advisers’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,000
Closed -$15K – 892
2025
Q3 		$15K Buy
+5,000
New +$13.7K ﹤0.01% 726

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Investment Advisers's ACHV Position: Q4 2025 in Review

FNY Investment Advisers sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 5,000 shares — an estimated $15K sold.

FNY Investment Advisers first reported a position in ACHV in Q3 2025 and held it in 1 quarter. The position peaked at $15K in Q3 2025. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.

  • FNY Investment Advisers reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 5,000 Achieve Life Sciences shares in Q4 2025, an estimated $15K.
  • FNY Investment Advisers first reported a position in Achieve Life Sciences in Q3 2025 and held it in 1 quarter.
  • FNY Investment Advisers's Achieve Life Sciences position peaked at $15K in Q3 2025.
  • 77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.